These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22387464)

  • 21. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.
    Shi J; Shi W; Ni L; Xu X; Su X; Xia L; Xu F; Chen J; Zhu J
    Oncol Rep; 2013 Jul; 30(1):201-6. PubMed ID: 23670345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of gene expression in porcine epiblast, hypoblast, trophectoderm and epiblast-derived neural progenitor cells.
    Gao Y; Jammes H; Rasmussen MA; Oestrup O; Beaujean N; Hall V; Hyttel P
    Epigenetics; 2011 Sep; 6(9):1149-61. PubMed ID: 21975513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oct4 and Sox2 directly regulate expression of another pluripotency transcription factor, Zfp206, in embryonic stem cells.
    Wang ZX; Teh CH; Kueh JL; Lufkin T; Robson P; Stanton LW
    J Biol Chem; 2007 Apr; 282(17):12822-30. PubMed ID: 17344211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells.
    Shin DM; Zuba-Surma EK; Wu W; Ratajczak J; Wysoczynski M; Ratajczak MZ; Kucia M
    Leukemia; 2009 Nov; 23(11):2042-51. PubMed ID: 19641521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Oct4 in maintaining and regaining stem cell pluripotency.
    Shi G; Jin Y
    Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional regulation of the Oct4 gene, a master gene for pluripotency.
    Kellner S; Kikyo N
    Histol Histopathol; 2010 Mar; 25(3):405-12. PubMed ID: 20054811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Modification Agents Improve Gene-Specific Methylation Reprogramming in Porcine Cloned Embryos.
    Huan Y; Wu Z; Zhang J; Zhu J; Liu Z; Song X
    PLoS One; 2015; 10(6):e0129803. PubMed ID: 26068219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical screen for epigenetic barriers to single allele activation of Oct4.
    Headley KM; Kedziora KM; Alejo A; Lai EZ; Purvis JE; Hathaway NA
    Stem Cell Res; 2019 Jul; 38():101470. PubMed ID: 31170660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications.
    Zhang X; He X; Li Q; Kong X; Ou Z; Zhang L; Gong Z; Long D; Li J; Zhang M; Ji W; Zhang W; Xu L; Xuan A
    Stem Cell Reports; 2017 May; 8(5):1256-1269. PubMed ID: 28494938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract.
    Freberg CT; Dahl JA; Timoskainen S; Collas P
    Mol Biol Cell; 2007 May; 18(5):1543-53. PubMed ID: 17314394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells.
    Ma DK; Chiang CH; Ponnusamy K; Ming GL; Song H
    Stem Cells; 2008 Aug; 26(8):2131-41. PubMed ID: 18535151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gradual DNA demethylation of the Oct4 promoter in cloned mouse embryos.
    Yamazaki Y; Fujita TC; Low EW; Alarcón VB; Yanagimachi R; Marikawa Y
    Mol Reprod Dev; 2006 Feb; 73(2):180-8. PubMed ID: 16245355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization of the Sox2, c-Myc, and Oct4 promoters.
    Chen H; Jin K; Song J; Zuo Q; Yang H; Zhang Y; Li B
    J Cell Biochem; 2019 Jan; 120(1):332-342. PubMed ID: 30277598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designer TAL effectors induce disease susceptibility and resistance to Xanthomonas oryzae pv. oryzae in rice.
    Li T; Huang S; Zhou J; Yang B
    Mol Plant; 2013 May; 6(3):781-9. PubMed ID: 23430045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid enhances Oct4 promoter activity in myogenic cells.
    Teng HF; Kuo YL; Loo MR; Li CL; Chu TW; Suo H; Liu HS; Lin KH; Chen SL
    J Cell Biochem; 2010 Jul; 110(4):995-1004. PubMed ID: 20564199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to 5-aza-2'-deoxycytidine in genic regions compared to non-genic repetitive sequences.
    Lim HW; Iwatani M; Hattori N; Tanaka S; Yagi S; Shiota K
    J Reprod Dev; 2010 Feb; 56(1):86-93. PubMed ID: 19996551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation.
    Fouse SD; Shen Y; Pellegrini M; Cole S; Meissner A; Van Neste L; Jaenisch R; Fan G
    Cell Stem Cell; 2008 Feb; 2(2):160-9. PubMed ID: 18371437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RG108 increases NANOG and OCT4 in bone marrow-derived mesenchymal cells through global changes in DNA modifications and epigenetic activation.
    Assis RIF; Wiench M; Silvério KG; da Silva RA; Feltran GDS; Sallum EA; Casati MZ; Nociti FH; Andia DC
    PLoS One; 2018; 13(12):e0207873. PubMed ID: 30507955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.